From how we diagnose a disease through to how we create new drugs to prevent and treat it, the digital transformation of life sciences is unstoppable and is pulling in serious capital. For Anna Strongman, chief executive of Oxford University
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.